3 In a recent meta-analysis, torsemide showed a trend toward a lower risk of heart failure hospitalization, odds ratio (OR) 0.72 (95% confidence interval [CI], 0.51 to 1.03), and a significant decrease in cardiac death OR 0.37 (95% CI, 0.20 to 0.66). 3 This was predominantly driven by the effect size of the Torsemide In Congestive Heart Failure study.
← all excerpts
Torsemide Is a More Appropriate Oral Loop Diuretic for Patients with Heart Failure: CON.
1
—
—